In this study, we found that SMS1 and SMS2 expression had an opposing impact on patient survival, which is in line with their divergent effects on GBM cell survival and is consistent with 2OHOA-induced activation of SMS1. This evidence concerns the gene SGMS2 and glioblastoma.